Details

Industries

Biotechnology,Life Science,Pharmaceutical

Founded date

Jan 1, 2013

Operating Status

Active

InoCard is a biotechnology company and develops AAV-based gene therapy approach for the long-term treatment of congestive heart failure, targeting the calcium-binding protein S100A1.